Insights

Insights From Our Experts

Articles

Balancing the Portfolio: How Extending Mature Brands’ Success Can Replenish Costs Invested In Launching New Products

The traditional mindset toward established brands in the pharmaceutical industry has largely been to let focus fade from them and shift entirely to developing and launching new products. With emphasis placed almost exclusively on new product…

Asset Optimization: Breathe New Life Into Mature Brands with EVERSANA REIGNITE™

Maximizing revenue potential throughout products’ entire lifecycles before they reach loss of exclusivity (LOE) is the most impactful return on investment manufacturers can make for their established brands. While many companies figuratively put their mature brands…

Continuous Manufacturing of Pharmaceutical Products: The New Norm

The life sciences sector is changing for the new pharma generation with the introduction of many forms of updated technology and solutions. Continuous manufacturing (CM) is a perfect example. CM is a method for manufacturing pharmaceutical…

Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and Canada

Discover the groundbreaking strategy that could redefine pharmaceutical launches and propel your product’s success across North America. In the realm of pharmaceutical launches, a paradigm shift is underway, challenging the conventional sequential approach and calling for…

Unlocking Global Success: The Crucial Role of Integrated HEOR Programs in New Product Launches

Author: Kirk Szafranski, Director, HEOR, Value & Evidence Health Economics and Outcomes Research (HEOR) programs play a pivotal role in assessing a product’s value, cost-effectiveness, and real-world impact on patient outcomes, which are critical factors influencing…

The Art of Simplifying Pharmacovigilance – Part V: Deconstructing Automation

The use of automation continues to be on the rise, and that trajectory is not slowing down anytime soon, if ever. In relation to pharmacovigilance, automation’s ascent and how it is impacting the industry is especially…

The Rising Demand for Light Medical Aesthetic in China

“The Rising Demand for Light Medical Aesthetic in China” provides a captivating insight into the surging popularity of non-surgical medical aesthetics in China. The article highlights the rapid growth of the medical aesthetic market and the…

Revolutionizing Vaccines: The Rise of mRNA Technology in China

Key Contributors: Robin Arnold, Executive Vice President; Renyang Liu, Engagement Manager; Nicole Li, Analyst Discover how mRNA technology is transforming the field of vaccines in China. From the evolution of vaccine development to the rapid progress…

Maximizing Potential: Essential Steps for Successful Commercialization of Cell and Gene Therapies

Introduction Cell and gene therapy (CGT) products have significantly enhanced the quality of life for millions of patients impacted by medical conditions that are untreatable with traditional medicines or surgeries such as certain cancers, inherited and…

Maximizing Product Launch Success: The Importance of Conducting Comprehensive Business Simulation Exercises

Product launch preparedness is a vital aspect of bringing new products to market, particularly in the pharmaceutical industry where patients’ health and well-being can be impacted, in addition to the brand’s success and overall reputation. As…